13 February 2017, India:
Bengaluru-based health technology startup SigTuple has raised $5.8 million in series A round of funding. The investment was led by existing investor Accel Partners, with participation from VC funds including Pi Ventures, VH Capital, Axilor Ventures, IDG Ventures and Endiya Partners as per a report.
“Our goal is to develop intelligent, scalable and affordable disease screening solutions which can empower the medical experts and facilitate quality health care delivery. Our initial focus is on the solutions for the screening tests so that we can positively impact a larger population not only in India but globally,” said Rohit Kumar Pandey, chief executive of SigTuple.
Also read- WHATSAPP UPGRADES SECURITY, INTRODUCES TWO-STEP VERIFICATION!
“Whichever healthcare market you look at, diagnostics and especially pathology is a large unfulfilled medical need and is a multi-billion dollar opportunity. With complexities and personalisation only increasing, taking away the subjective element of human intervention is a key aspect in addressing these issues,” said Barath Shankar Subramanian, principal, Accel Partners. “SigTuple’s solution is a powerful tool that has the potential to make the aspect of diagnostics significantly more efficient, accurate and quicker.”
Founded by Rohit Kumar Pandey, Tathagato Rai Dastidar and Apurv Anand, SigTuple will utilize the latest round of funding for business expansion, building the team and taking the product to the user-adoption stage followed by commercialisation, as well as obtain regulatory clearances for global markets.
SigTuple aims to create a data-driven, machine learned, cloud-based solution for detection of abnormalities and trends in medical data, which improves the accuracy and efficiency of disease diagnosis.
